Brief: Evaxion Biotech Q3 Basic EPS USD -0.04
31/10/2024 12:00
Oct 31 (Reuters) - Evaxion Biotech Q3 net income USD -1.935 million. * Q3 operating income USD -1.731 million * Q3 pretax profit USD -2.031 million
Recent news on Evaxion A/S
See all newsEvaxion A/S reports results for the quarter ended June 30 - Earnings Summary
Denmark's Evaxion Q2 net loss narrows on lower expenses
Brief: Evaxion Q2 Basic EPS USD -0.01
Evaxion A/S expected to post a loss of 31 cents a share - Earnings Preview
Brief: Evaxion A/S - Expands Pipeline Of Cancer Vaccine Programs With Evx-05 Against Brain Cancer Glioblastoma